Chemours Co (CC)
Working capital turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 5,818,000 | 6,638,000 | 6,139,000 | 4,737,000 | 5,318,000 |
Total current assets | US$ in thousands | 3,835,000 | 3,214,000 | 3,345,000 | 2,633,000 | 2,777,000 |
Total current liabilities | US$ in thousands | 2,486,000 | 1,891,000 | 1,858,000 | 1,442,000 | 1,541,000 |
Working capital turnover | 4.31 | 5.02 | 4.13 | 3.98 | 4.30 |
December 31, 2023 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $5,818,000K ÷ ($3,835,000K – $2,486,000K)
= 4.31
The working capital turnover for Chemours Co has shown some fluctuations over the past five years. In 2023, the working capital turnover was 4.31, slightly lower than the previous year's ratio of 5.02. This indicates that the company generated approximately $4.31 in net sales for every dollar of working capital invested in the business in 2023.
Compared to 2021 and 2020, where the ratios were 4.13 and 3.98 respectively, the company performed better in terms of utilizing its working capital to generate sales in 2023. However, it was slightly lower than the ratio of 4.30 in 2019.
Overall, the working capital turnover ratio for Chemours Co has displayed some variability in recent years, but the general trend suggests a relatively efficient use of working capital to support sales activities. Further analysis would be required to understand the factors contributing to these fluctuations and assess the company's overall financial performance.
Peer comparison
Dec 31, 2023